Ganesha Lab
AcceleratorActively deployingSantiago · Pre-Seed–Seed
Investment thesis
The Ganesha Lab operates as a scale-up lab focused on high-potential, science-based startups in the life sciences. Based in Latin America with a global outlook, it works to transform early science-driven ventures into successful, scalable international companies. Its support model emphasizes strategic mentoring, preparing founders for investor engagement, and opening access to global markets, with the broader aim of driving innovation and improving lives worldwide.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 2 of 42 portfolio companiesBiotech ×2Digital Health ×1Medical Devices ×1
HQs:United Kingdom×1United States×1
Portfolio companies · 42 tracked
alumni founders can tell you what the program is really likeBiotechLaredo, US
Alejandro Abarca Blanco(Executive Officer, Director)Liza Velarde(Executive Officer, Director)Joost Leeflang(Director)Juan Yee de Leon(Executive Officer, Director)
Trears Biomarkers is a MedTech company developing non-invasive, earwax-based diagnostic tests for detecting and monitoring chronic diseases.
BiotechDigital HealthMedical Devices
Frequently asked questions
- What stage does Ganesha Lab invest at?
- Ganesha Lab invests at the Pre-Seed, Seed stages.
- What is Ganesha Lab's typical check size?
- Ganesha Lab typically writes checks of $200K.
- What sectors does Ganesha Lab focus on?
- Ganesha Lab focuses on Biotech, Deep Tech, Healthtech.
- Where is Ganesha Lab located?
- Ganesha Lab is headquartered in Santiago, CL.
From the blog
visit blog ↗Ganesha Lab recently wrote about establishing a new biotech accelerator hub in São Paulo connecting Latin American startups to global investors and healthcare innovation networks, hosting a curated business mission to deep tech conferences, and participating in regional DeepTech ecosystem-building efforts focused on bridging scientific research with market-ready products. AI summary
Images
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Boundary Capital invests in high-growth private technology companies with the aim of positively impacting millions of lives, focusing on life sciences, AI, and engineering.
Canaan is an early-stage venture capital firm backing founders with transformative ideas across technology and healthcare.